Barry Quart, Heron Therapeutics CEO
Heron secures FDA approval after R&D head count chop
The FDA just gave Heron Therapeutics a win for its post-surgery nausea and vomiting drug — and its fourth approval so far.
The San Diego biotech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
